1 week ago

Adobe (ADBE) Stock Gains 1.8% Following CX Enterprise AI Agent Platform Launch

Adobe (ADBE) stock climbed 1.8% Monday following the launch of CX Enterprise, an AI agent platform for businesses, despite being d...

1 week ago

Clearmind Medicine (CMND) Stock Doubles as CMND-100 Passes Critical Safety Miles...

Clearmind Medicine (CMND) stock doubled after CMND-100 achieved its primary safety endpoint in a Phase I/IIa AUD trial with no ser...

1 week ago

Enveric Biosciences (ENVB) Stock Explodes 160%+ Following Trump’s Psychedelic Ex...

Enveric Biosciences (ENVB) stock exploded 160%+ after Trump's executive order to accelerate psychedelic drug reviews and $50M ibog...

1 week ago

COMPASS Pathways (CMPS) Stock Soars 25% on Trump’s Psychedelics Research Order

COMPASS Pathways (CMPS) stock jumped 25% after Trump's executive order on psychedelic research. Positive Phase 3 data boosts inves...

1 week ago

5 Leading Cloud Infrastructure Stocks on Analysts’ Radars for 2026

Discover the top 5 cloud infrastructure stocks for 2026: Microsoft, Nvidia, Amazon, Broadcom, and Arista lead with strong growth a...

1 week ago

Rocket Lab (RKLB) Stock: Wall Street Analysts Raise Price Targets Amid Mynaric A...

Rocket Lab (RKLB) stock receives $105 price target from Stifel amid multiple Buy ratings. Insiders sell shares while Mynaric acqui...

1 week ago

Robinhood (HOOD) Stock Climbs as Mizuho Boosts Price Target to $115 on Regulator...

Mizuho upgrades Robinhood (HOOD) to $115 as SEC removes $25K Pattern Day Trader rule. Learn why analysts expect revenue growth fro...

1 week ago

Definium Therapeutics (DFTX) Stock Soars to New Heights on Trump’s Psychedelic R...

Definium Therapeutics (DFTX) stock surged 13% premarket as Trump's Executive Order accelerates psychedelic drug research for menta...

1 week ago

Theriva Biologics (TOVX) Stock Soars 63% on Promising Pancreatic Cancer Trial Re...

Theriva Biologics (TOVX) stock surged 63% after Phase 2b trial data revealed VCN-01 plus chemo improved survival in metastatic pan...

1 week ago

Salesforce (CRM) Stock Plunges 30% YTD as AI Threatens Traditional SaaS Revenue...

Salesforce (CRM) stock has fallen 30% in 2026 amid AI disruption fears. CEO Benioff counters with Agent Albert launch and Agentfor...